Zions Bancorporation National Association UT Has $231,000 Holdings in Acadia Healthcare Company, Inc. $ACHC

Zions Bancorporation National Association UT cut its holdings in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 37.2% during the second quarter, Holdings Channel reports. The fund owned 10,164 shares of the company’s stock after selling 6,027 shares during the period. Zions Bancorporation National Association UT’s holdings in Acadia Healthcare were worth $231,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Hawk Ridge Capital Management LP grew its holdings in shares of Acadia Healthcare by 437.5% during the first quarter. Hawk Ridge Capital Management LP now owns 2,473,226 shares of the company’s stock worth $74,988,000 after purchasing an additional 2,013,126 shares during the last quarter. Citigroup Inc. lifted its position in Acadia Healthcare by 5,144.2% during the 1st quarter. Citigroup Inc. now owns 2,376,209 shares of the company’s stock worth $72,047,000 after buying an additional 2,330,898 shares in the last quarter. Maverick Capital Ltd. grew its holdings in Acadia Healthcare by 116.3% during the 1st quarter. Maverick Capital Ltd. now owns 2,246,923 shares of the company’s stock worth $68,127,000 after acquiring an additional 1,208,296 shares during the last quarter. Abrams Bison Investments LLC acquired a new stake in Acadia Healthcare in the 1st quarter valued at about $55,182,000. Finally, Khrom Capital Management LLC raised its stake in shares of Acadia Healthcare by 26.9% in the first quarter. Khrom Capital Management LLC now owns 1,587,299 shares of the company’s stock worth $48,127,000 after acquiring an additional 336,297 shares during the last quarter.

Analyst Upgrades and Downgrades

Several research analysts recently weighed in on the stock. KeyCorp dropped their price objective on shares of Acadia Healthcare from $55.00 to $35.00 and set an “overweight” rating for the company in a research report on Wednesday, October 8th. Cantor Fitzgerald dropped their target price on Acadia Healthcare from $25.00 to $22.00 and set a “neutral” rating for the company in a research report on Friday. Royal Bank Of Canada decreased their price target on Acadia Healthcare from $43.00 to $28.00 and set an “outperform” rating on the stock in a report on Wednesday, August 13th. UBS Group dropped their price objective on Acadia Healthcare from $31.00 to $28.00 and set a “buy” rating for the company in a report on Friday. Finally, Guggenheim reduced their target price on shares of Acadia Healthcare from $29.00 to $27.00 and set a “buy” rating on the stock in a research note on Monday. Eight equities research analysts have rated the stock with a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, Acadia Healthcare has an average rating of “Moderate Buy” and a consensus target price of $33.36.

Acadia Healthcare Trading Down 6.9%

NASDAQ:ACHC opened at $18.17 on Tuesday. The company has a current ratio of 1.32, a quick ratio of 1.32 and a debt-to-equity ratio of 0.73. Acadia Healthcare Company, Inc. has a 1-year low of $17.13 and a 1-year high of $47.08. The firm has a market capitalization of $1.68 billion, a price-to-earnings ratio of 12.03, a PEG ratio of 4.56 and a beta of 0.97. The business’s 50-day moving average price is $23.25 and its two-hundred day moving average price is $22.78.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings results on Wednesday, November 5th. The company reported $0.72 EPS for the quarter, beating analysts’ consensus estimates of $0.71 by $0.01. Acadia Healthcare had a return on equity of 8.34% and a net margin of 4.31%.The company had revenue of $851.57 million during the quarter, compared to analysts’ expectations of $852.43 million. During the same period in the prior year, the business posted $0.91 EPS. Acadia Healthcare’s revenue was up 4.4% on a year-over-year basis. Acadia Healthcare has set its FY 2025 guidance at 2.350-2.450 EPS. On average, equities analysts expect that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current year.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.